Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
5 trials
Recent
Start date
Enrollment
Parkinson Disease 4, Autosomal Dominant Lewy Body
×
lenvatinib
×
Dermatologic
×
Clear all
Filters
3
NCT03820986
2026-02-09
LEAP-003
Merck Sharp & Dohme LLC
Phase 3
Completed
674 enrolled
21 charts
NCT04889118
2025-12-23
LEAP-003
Merck Sharp & Dohme LLC
Phase 3
Completed
131 enrolled
16 charts
NCT04700072
2025-10-28
KEYMAKER-U02
Merck Sharp & Dohme LLC
Phase 1/2
Completed
56 enrolled
NCT04305041
2025-08-29
KEYMAKER-U02
Merck Sharp & Dohme LLC
Phase 1/2
Completed
100 enrolled
NCT04305054
2025-08-29
KEYMAKER-U02
Merck Sharp & Dohme LLC
Phase 1/2
Active not recruiting
315 enrolled